Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• 1. Advances in monitoring hydratase activity R Wanders2. Biomarkers of bone and mineral metabolism following bone marrow transplantation Moo-Il Kang 3. Biochemical basis of Fabry disease A Das4. Factor V Leiden and activated protein C resistance E Castoldi5. Anti-glycan antibodies Nir Dotan6. Biomarkers in sleep disorders Kazuhiko Kotani7. Colorectal Cancer Lynne Thadikkaran8. Proteomics in lung cancer diagnosis Je-Yoel Cho9. Gluco-markers in disease states Giovanni Misciagna10. Advances in Pregnancy testing Pasquale Florio

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• 1. Advances in monitoring hydratase activity R Wanders2. Biomarkers of bone and mineral metabolism following bone marrow transplantation Moo-Il Kang 3. Biochemical basis of Fabry disease A Das4. Factor V Leiden and activated protein C resistance E Castoldi5. Anti-glycan antibodies Nir Dotan6. Biomarkers in sleep disorders Kazuhiko Kotani7. Colorectal Cancer Lynne Thadikkaran8. Proteomics in lung cancer diagnosis Je-Yoel Cho9. Gluco-markers in disease states Giovanni Misciagna10. Advances in Pregnancy testing Pasquale Florio

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

• 1. Advances in monitoring hydratase activity R Wanders2. Biomarkers of bone and mineral metabolism following bone marrow transplantation Moo-Il Kang 3. Biochemical basis of Fabry disease A Das4. Factor V Leiden and activated protein C resistance E Castoldi5. Anti-glycan antibodies Nir Dotan6. Biomarkers in sleep disorders Kazuhiko Kotani7. Colorectal Cancer Lynne Thadikkaran8. Proteomics in lung cancer diagnosis Je-Yoel Cho9. Gluco-markers in disease states Giovanni Misciagna10. Advances in Pregnancy testing Pasquale Florio